GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma.

Authors:
Ni L; Chen S; Liu J; Li H; Zhao H and 6 more

Journal:
Mediators Inflamm

Publication Year: 2023

DOI:
10.1155/2023/7123568

PMCID:
PMC10132901

PMID:
37124060

Journal Information

Full Title: Mediators Inflamm

Abbreviation: Mediators Inflamm

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflicts of interest."

Evidence found in paper:

"This work was supported by the Fujian Natural Science Foundation Project (2021J011262), Fund for Distinguished Young Scholars of 900TH Hospital (No. 2021JQ08), Intra-Hospital Project of 900TH Hospital of Joint Logistics Support Force (Nos. 2020L27 and 2019L10), and startup fund for scientific research of Fujian Medical University (2020QH1250, 2021QH1321, and 2021QH1322). Ethical Approval: The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of 900TH Hospital of Joint Logistics Support Force."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025